Implications of Proprotein Convertases in Ovarian Cancer Cell Proliferation and Tumor Progression: Insights for PACE4 as a Therapeutic Target.
about
Cationic Cell-Penetrating Peptides Are Potent Furin Inhibitors.Expression of paired basic amino acid-cleaving enzyme 4 (PACE4) correlated with prognosis in non-small cell lung cancer (NSCLC) patients.Identification of potent and compartment-selective small molecule furin inhibitors using cell-based assays.Liver-Specific Inactivation of the Proprotein Convertase FURIN Leads to Increased Hepatocellular Carcinoma Growth.PACE4 regulates apoptosis in human prostate cancer cells via endoplasmic reticulum stress and mitochondrial signaling pathways.Multi-Leu PACE4 Inhibitor Retention within Cells Is PACE4 Dependent and a Prerequisite for Antiproliferative Activity.PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation.PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.The proprotein convertase furin in tumour progression.A multiplex platform for the identification of ovarian cancer biomarkersRational Design of a Highly Potent and Selective Peptide Inhibitor of PACE4 by Salt Bridge Interaction with D160 at Position P3.Furin inhibitor D6R suppresses epithelial-mesenchymal transition in SW1990 and PaTu8988 cells via the Hippo-YAP signaling pathway.Proprotein convertase subtilisin/kexin type 6 activates the extracellular signal-regulated kinase 1/2 and Wnt family member 3A pathways and promotes in vitro proliferation, migration and invasion of breast cancer MDA-MB-231 cells.Evaluation of PACE4 isoforms as biomarkers in thyroid cancer
P2860
Q35673837-A5356672-8092-4B17-A921-21A734FCD830Q35681045-F2F16C0E-519C-4573-ADE0-9ED8084400EBQ35744263-F75225B4-246B-4D8F-A4D4-5F383B841B3EQ35763764-AF5390D5-8989-4F21-91DB-0E160E64B0C1Q35851953-D8C7E07D-60DB-41C9-9F56-F9FDF62A3687Q38859830-C558743D-13AA-49B2-9DA0-4EB9B4BDCBA6Q38909525-420748ED-6CC3-4922-97B9-D75BCA51F67FQ38956599-C277F5CD-5E9C-4509-81EA-EFEB0859C01EQ39215671-800B7EC0-2625-4B11-8789-25680267F374Q42374131-FC3A2E3E-7910-41B9-9C9A-63B05A108040Q48102100-E98A8037-DCEF-4058-979F-5BAFACD65A03Q50053243-3955019E-F717-4D36-9540-C4E0C0662C0FQ55398346-6503F213-8724-49AF-8488-F1058B8972CFQ57810683-0BCEFBB9-BA85-4246-AEC0-196626270A2E
P2860
Implications of Proprotein Convertases in Ovarian Cancer Cell Proliferation and Tumor Progression: Insights for PACE4 as a Therapeutic Target.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Implications of Proprotein Con ...... PACE4 as a Therapeutic Target.
@ast
Implications of Proprotein Con ...... PACE4 as a Therapeutic Target.
@en
Implications of Proprotein Con ...... PACE4 as a Therapeutic Target.
@nl
type
label
Implications of Proprotein Con ...... PACE4 as a Therapeutic Target.
@ast
Implications of Proprotein Con ...... PACE4 as a Therapeutic Target.
@en
Implications of Proprotein Con ...... PACE4 as a Therapeutic Target.
@nl
prefLabel
Implications of Proprotein Con ...... PACE4 as a Therapeutic Target.
@ast
Implications of Proprotein Con ...... PACE4 as a Therapeutic Target.
@en
Implications of Proprotein Con ...... PACE4 as a Therapeutic Target.
@nl
P2093
P2860
P50
P1476
Implications of Proprotein Con ...... PACE4 as a Therapeutic Target
@en
P2093
Anna Kwiatkowska
Christine Levesque
Frédéric Couture
Michelle Maffia
Robert Day
Roxane Desjardins
Rémi Longuespée
Sandra Gagnon
P2860
P356
10.1016/J.TRANON.2014.04.008
P577
2014-05-09T00:00:00Z